Differences in microRNA expression between melanoma and healthy adjacent skin
Open Access
- 5 January 2019
- journal article
- research article
- Published by Springer Nature in BMC Dermatology
- Vol. 19 (1), 1
- https://doi.org/10.1186/s12895-018-0081-1
Abstract
The tumor microenvironment is composed of cancer-associated fibroblasts, tumor-associated macrophages, endothelial cells, immune cells, signaling molecules and extracellular matrix structures, which closelycommunicate with the tumor via multiple mechanisms. MicroRNAs are paracrine regulators that provide a direct interaction between the microenvironment and cancer cells. In the presentstudy, we aimed to identify the microRNA expression profile in melanoma compared with thatin healthy adjacent skin, with a further assessment of altered microRNA signaling pathways and target genes. Formalin-fixed paraffin-embedded (FFPE) melanoma tissue samples were separated by dissection into tumor and surrounding health tissue fragments. MicroRNA expression profiles were obtained by microarray using Gene Atlas Microarray System (Affymetrix, California, USA). To confirm microarray results real-time PCR was carried out. Bioinformatic analysis was performed using the DIANA-miRPath v.3.0 database. Target genes for miR-146a-5p were determined using three algorithms: TargetScan 7.0, miRWalk 2.0 and miRTarBase v.4.5. A microarray profiling revealed 143 microRNAs asdifferent in tumor versus adjacent tissues. Expression level of hsa-miR-146a-5p showedto be higher in melanoma cells as compared to thehealthy adjacent skin. The bioinformatic study has determined several signaling cascades associated with miR-146a-5p:Toll-like receptor pathway, NF-κB pathway, ErB pathway, and measles signaling pathway. The 38 target genes have been shown for miR-146a-5p of which NRAS gene is known asone of the most frequent mutated in melanoma. Elucidation of the role of miR-146-a-5p in complex interactions between the tumor and the cells of healthy adjacent skin is necessary for our understanding of the mechanisms oftumor progression. Significant differences found between cancer cells and adjacent tissues in microRNA expression profile corresponding to divergent mRNA/protein levels in these structures should be taken into account when tumor samples characterization estimatedby high-throughput methods.Funding Information
- Russian Science Foundation (project №14-15-00074P)
This publication has 31 references indexed in Scilit:
- Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin JBMC Cancer, 2017
- Microenvironment-derived factors driving metastatic plasticity in melanomaNature Communications, 2017
- Family of microRNA-146 Regulates RARβ in Papillary Thyroid CarcinomaPLOS ONE, 2016
- Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stromaMolecular Oncology, 2015
- MicroRNAs in cancer: from developmental genes in worms to their clinical application in patientsBritish Journal of Cancer, 2015
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic LiaisonInternational Journal of Cell Biology, 2012
- MicroRNA: Biogenesis, Function and Role in CancerCurrent Genomics, 2010
- Epigenetically Reprogramming Metastatic Tumor Cells With An Embryonic MicroenvironmentEpigenomics, 2009
- MicroRNAs in human cancer: from research to therapyJournal of Cell Science, 2007